Allergan Announces Retirement of Board Member William Grant.Business Editors IRVINE, Calif.--(BUSINESS WIRE)--Nov. 18, 2002 Allergan (NYSE NYSE See: New York Stock Exchange :AGN AGN Again (Amateur Radio) AGN Active Galactic Nucleus AGN Acute Glomerulonephritis AGN Accountants Global Network AGN Air Gabon (ICAO code) ) today announced that in connection with the spin out of Advanced Medical Optics Advanced Medical Optics, Inc., (NYSE: EYE) (known as AMO) is a global medical device leader focused on the discovery and delivery of innovative vision technologies that optimize the quality of life for people of all ages. ("AMO AMO - America's Multimedia Online ") (NYSE:AVO a·vo n. pl. a·vos See Table at currency. [Portuguese, shortened from oitavo, eighth, from Latin oct ) by Allergan on July 1, 2002, and the assumption by William R. Grant of the position as Chairman of the Board of AMO, William Grant has retired as a director of Allergan, Inc., effective November 18, 2002. As part of a private letter ruling request to the IRS An abbreviation for the Internal Revenue Service, a federal agency charged with the responsibility of administering and enforcing internal revenue laws. regarding the spin out of AMO, no director of Allergan is to remain both a director of AMO and of Allergan for more than one year following the spin out of AMO. "Since joining Allergan's Board of Directors in 1989, Mr. Grant has been an invaluable and insightful Director, blessing Allergan's Board with his outstanding judgment, knowledge of healthcare, and financial expertise," said David E.I. Pyott, Allergan's Chairman of the Board, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "Although Bill will be missed by Allergan's Board, I am excited that AMO will have the benefit of such an insightful leader and great entrepreneur." Forward-Looking Statements Statements regarding future plans, forecasts, and events are "forward-looking statements." These statements are based on current expectations and intentions only. If underlying assumptions prove inaccurate, or unknown risks or uncertainties materialize, actual results could vary materially from the Company's expectations. Information concerning risk factors can be found in press releases issued by Allergan as well as Allergan's public periodic filings with the Securities and Exchange Commission, including the discussion under the heading "Certain Factors and Trends Affecting Allergan and Its Businesses" in Allergan's 2001 Annual Report on Form 10-K and Form 10-Q for the quarter ended June 28, 2002. Allergan's filings are available publicly and upon request from Allergan's Investor Relations Department at 714/246-4636. About Allergan, Inc. Allergan, Inc., with headquarters in Irvine, California, is a technology-driven, global health care company providing eye care and specialty pharmaceutical products worldwide. Allergan develops and commercializes products in the eye care, neuromodulator and skin care markets that deliver value to our customers, satisfy unmet medical needs and improve patients' lives. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion